SGPSpyGlass Pharma, Inc.Earnings in 9 days

Nasdaq GSBiotechnologyMarket cap $1.00BReports Nov 5, 2026

SpyGlass Pharma, Inc.

Vision and ophthalmology
Sector
Healthcare
Industry
Biotechnology
Market cap
$1.00B
Employees
76
Exchange
Nasdaq GS
Country
United States
29.91+5.02% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Automated read

There is not enough moving-average history yet for a mid-term technical read.

Readings, end-of-day Oct 26, 2026
RSI (14)Upper-neutral62.88, favorable reading
MACD / signalAbove signal line0.17 / -0.31, favorable reading
SMA 50Price above26.68, favorable reading
SMA 200——
EMA 20Price above26.09, favorable reading
ADX (14)Firming23.24
Show all 12 readings
+DI / −DI+DI leading22.69 / 18.33, favorable reading
ATR (14)4.9% of price — typical daily swing1.45
Stochastic %KOverbought zone96.27, flagged reading
Bollinger bands (20)Above upper band: stretched22.64 – 28.26
ROC (10)Positive over 10 sessions14.29, favorable reading
Trend / momentum impulseTrend and momentum agreeBoth rising, favorable impulse reading
Full analysis

What unlocking SGP reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when SGP's analysis runs, rather than checked against its stored data now.

Every section above, argued on SGP's own numbers, on one page.

See what SGP costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full SGP analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get SGP + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does SpyGlass Pharma, Inc. report earnings?

SpyGlass Pharma, Inc. (SGP) is scheduled to report earnings on Nov 5, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock SGP